P

Phio Pharmaceuticals Corp
D

PHIO

2.46000
USD
0.00
(0.00%)
Market Closed
Volume
202
EPS
-16
Div Yield
-
P/E
-0
Market Cap
2,595,839
OverviewSignalsIdeasNews
Related Instruments
    A
    ABUS
    0.01000
    (0.28%)
    3.64000 USD
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    V
    VIR
    -0.63500
    (-7.35%)
    8.01000 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    More
News

Title: Phio Pharmaceuticals Corp

Sector: Healthcare
Industry: Biotechnology
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.